STAT September 3, 2020
WASHINGTON — A group of prominent biotech CEOs are calling on their peers and the federal government to hold themselves to the highest standards when it comes to developing and reviewing Covid-19 treatments.
Among their demands: That biotech companies don’t simply release clinical trial data in press releases, and that federal regulators make it clear to the public that any vaccines or treatments will be approved strictly based on science.
The recommendations were laid out in an open letter organized by the Biotechnology Innovation Organization and published Thursday. The letter comes amid growing concern among the American public over the politicization of the Covid-19 pandemic. A new poll conducted by STAT and Harris Poll found that nearly 80% of Americans...